Selected article for: "available vaccine and effective vaccine"

Author: Famuyiro, Tolulope B.; Ogunwale, Abayomi; des Bordes, Jude; Raji, Mukaila
Title: COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers
  • Cord-id: 8uyekfcc
  • Document date: 2021_7_15
  • ID: 8uyekfcc
    Snippet: BACKGROUND: The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response b
    Document: BACKGROUND: The health and economic ramifications of the coronavirus pandemic have prompted the need for a timely and effective vaccine development. While the rollout of the COVID-19 vaccine in record time is being hailed as a scientific feat, skepticism about the safety, side effects, and even its long-term effects remain. Acceptance of the vaccine may therefore be a challenge among healthcare workers (HCWs), whose role is considered a proxy to determining the COVID-19 vaccine uptake response by the general population. METHODS: In December 2020, prior to the arrival and receipt of the Pfizer-BioNTech and Moderna COVID-19 vaccine, we conducted a cross-sectional survey to assess the readiness for vaccine uptake among HCWs at three community-based, university-affiliated health centers. RESULTS: A total of 205 (82%) respondents out of 250 completed the questionnaire. Fifty-four percent of respondents agreed to receive vaccine once available. Females (odds ratio (OR) =0.22, p=0.014), non-Hispanic Blacks (OR=0.066, p=0.010), and Hispanics (OR=0.11, p=0.037) were less likely to accept the vaccine. Respondents with moderate-risk perception were more likely to accept (OR=2.79, p=0.045) compared to those with low-risk perception while no association was found between high-risk perception and vaccine acceptance (p=0.226). After adjusting for perceived risk, sex, race/ethnicity, and age, acceptance in non-Hispanic Black population remained statistically significant (adjusted OR=0.07, p=0.014), with Hispanic (AOR=0.12, p=0.051) showing a trend. CONCLUSIONS: Enthusiastic acceptance of the COVID-19 vaccine is lacking among surveyed HCWs of certain racial/ethnic groups. Provision of resources and public health interventions targeting underserved, minority populations are necessary to halt opposition to vaccine uptake.

    Search related documents:
    Co phrase search for related documents
    • accept likely and acute respiratory disease coronavirus: 1, 2
    • accept likely and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accept likely and low uptake: 1, 2, 3, 4
    • acceptance readiness and logistic regression: 1
    • active immunization and acute respiratory disease: 1, 2, 3, 4, 5, 6
    • active immunization and acute respiratory disease coronavirus: 1, 2, 3, 4
    • active role and acute respiratory disease: 1, 2, 3, 4, 5, 6
    • active role and acute respiratory disease coronavirus: 1, 2, 3, 4, 5
    • active role and logistic regression: 1, 2, 3, 4
    • active role and low uptake: 1
    • acute respiratory disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory disease and logistic regression analyze: 1
    • acute respiratory disease and long term effect: 1
    • acute respiratory disease and long term immediate: 1, 2
    • acute respiratory disease and low uptake: 1
    • acute respiratory disease coronavirus and logistic regression analyze: 1, 2
    • acute respiratory disease coronavirus and long term effect: 1
    • acute respiratory disease coronavirus and long term immediate: 1, 2
    • acute respiratory disease coronavirus and low uptake: 1